Given the importance of the TGF‐β and PD‐L1 pathways in the development of cancer, the simultaneous inhibition of these pathways may potentially enhance the antitumor activity observed when each pathway is targeted alone (Fig. 2). The gene discussed is CD274; the disease is cancer.